Country: United Kingdom
Language: English
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Norethisterone acetate; Estradiol
Bayer Plc
G03CA53
Norethisterone acetate; Estradiol
1mg ; 2mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 06040101; GTIN: 5016703004738
015_0 Page 1 of 9 Due to regulatory changes, the content of the following Patient Information Leaflet may vary from the one found in your medicine pack. Please compare the 'Leaflet prepared/revised date' towards the end of the leaflet to establish if there have been any changes. If you have any doubts or queries about your medication, please contact your doctor or pharmacist. _ _ _ _ PACKAGE BOOKLET: INFORMATION FOR THE USER NUVELLE CONTINUOUS Estradiol and norethisterone acetate READ ALL OF THIS BOOKLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Keep this booklet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this booklet. See section 4. WHAT IS IN THIS BOOKLET 1. What Nuvelle Continuous is and what it is used for……..……………………………………………. 2. What you need to know before you take Nuvelle Continuous……………………………….………… MEDICAL HISTORY AND REGULAR CHECK-UPS ................................................................................. ……….…....... DO NOT TAKE NUVELLE CONTINUOUS ................................................................................................................... WARNINGS AND PRECAUTIONS ............................................................................................................................. HRT AND CANCER.…………………………………………………………………………………………………. EFFECT OF HRT ON HEART OR CIRCULATION ............................................................................................................ BLOOD CLOTS IN A VEIN (THROMBOSIS)….………… Read the complete document
OBJECT 1 NUVELLE CONTINUOUS Summary of Product Characteristics Updated 10-Oct-2017 | Bayer plc 1. Name of the medicinal product Nuvelle Continuous 2. Qualitative and quantitative composition Each tablet contains: Estradiol (as hemihydrate) 2.0 mg Norethisterone acetate 1.0 mg Excipient with known effect Lactose monohydrate. Each tablet contains 50.3 mg lactose monohydrate. For the full list of excipients, see section 6.1. 3. Pharmaceutical form Film-coated tablets. Each tablet is pink. 4. Clinical particulars 4.1 Therapeutic indications Hormone replacement therapy (HRT) for oestrogen deficiency symptoms in postmenopausal women with an intact uterus more than 1 year post menopause. Prevention of osteoporosis in postmenopausal women at high risk of future fractures who are intolerant of, or contraindicated for, other medicinal products approved for the prevention of osteoporosis. See also Section 4.4. 4.2 Posology and method of administration • POSOLOGY Nuvelle Continuous is a continuous combined HRT product. One tablet is taken daily. Each pack covers 28 days of treatment. It does not matter at what time of day the woman takes her tablet, but once she has selected a particular time, she should keep to it every day. Treatment is continuous, which means that the next pack follows immediately without a break. For initiation and continuation of treatment of postmenopausal symptoms, the lowest effective dose for the shortest duration (see also Section 4.4) should be used. Unless there is a previous diagnosis of endometriosis, it is not recommended to add a progestogen in hysterectomised women. • How to start Nuvelle Continuous Women without prior hormone replacement therapy and those changing from another continuous combined hormone replacement therapy may start Nuvelle Continuous at any time. Women changing from a continuous sequential or cyclical hormone replacement therapy should complete the cycle and then change to Nuvelle Continuous without a break in therapy. • Missed or lost tablets If the woman forgets Read the complete document